Clinical trials
Phase 2 Lung Diseases trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
61 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 1 |
| 2002 | 2 |
| 2003 | 2 |
| 2004 | 1 |
| 2005 | 2 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 2 |
| 2009 | 4 |
| 2010 | 1 |
| 2011 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 4 |
| 2017 | 3 |
| 2018 | 5 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 3 |
| 2023 | 2 |
| 2024 | 5 |
| 2025 | 7 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 30 |
| Recruiting | 14 |
| Terminated | 10 |
| Active, not recruiting | 4 |
| Withdrawn | 3 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pfizer | 4 |
| AstraZeneca | 3 |
| Eli Lilly and Company | 3 |
| Vertex Pharmaceuticals Incorporated | 3 |
| Bastiaan Driehuys | 2 |
| Complexa, Inc. | 2 |
| H. Lee Moffitt Cancer Center and Research Institute | 2 |
| Novartis Pharmaceuticals | 2 |
| Pulmovant, Inc. | 2 |
| University of New Mexico | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lung Diseases | 61 |
| Respiratory Tract Diseases | 19 |
| Asthma | 9 |
| Lung Neoplasms | 9 |
| Fibrosis | 8 |
| Bronchial Diseases | 7 |
| Cystic Fibrosis | 7 |
| Lung Diseases, Interstitial | 7 |
| Carcinoma | 6 |
| Idiopathic Pulmonary Fibrosis | 6 |
Trials
Showing 1 to 25 of 61. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.